Twist Bioscience (TWST)
(Delayed Data from NSDQ)
$31.54 USD
+0.46 (1.48%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $31.53 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TWST 31.54 +0.46(1.48%)
Will TWST be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TWST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TWST
Twist Bioscience (TWST) Soars 12.5%: Is Further Upside Left in the Stock?
5 Best Performing Stocks of the Top ETF of November
TWST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
Blueprint Medicines (BPMC) Reports Q3 Loss, Tops Revenue Estimates
Bayer (BAYRY) Partners Twist Bioscience for Drug Discovery
Other News for TWST
First Week of June 21st Options Trading For Twist Bioscience (TWST)
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Cathie Wood's ARK Investment bought 133K shares of Twist Bioscience today
Twist Bioscience price target lowered by $5 at Barclays, here's why
Analyst Scoreboard: 5 Ratings For Twist Bioscience